Manus Bio receives additional funding to combat malaria
Fourth award from the Bill & Melinda Gates Foundation will support artemisinin research
Read MoreFourth award from the Bill & Melinda Gates Foundation will support artemisinin research
Read MoreFollowing a successful collaboration, the companies will now partner to focus on precision medicine
Read MoreHertfordshire Trust to invest in mental health care with wide-ranging digital assessment platform
Read MoreTherapy is a biosimilar of Lucentis which treats several serious retinal diseases across the European Union
Read MoreIt is estimated that every year more than 6,300 people will be diagnosed with CML in Europe
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
